...
首页> 外文期刊>Der Pharma Chemica: journal for medicinal chemistry, pharmaceutical chemistry and computational chemistry >Diastereoselective synthesis of (3r, 3as, 6ar)-hexahydrofuro [2, 3-b] furan-3-Yl (2r, 3r)-4-(4-amino-N-isobutylphenylsulfo- namido)-3- hydroxy-1-phenylbutan-2-ylcarbamate (diastereomer of darunavir)
【24h】

Diastereoselective synthesis of (3r, 3as, 6ar)-hexahydrofuro [2, 3-b] furan-3-Yl (2r, 3r)-4-(4-amino-N-isobutylphenylsulfo- namido)-3- hydroxy-1-phenylbutan-2-ylcarbamate (diastereomer of darunavir)

机译:(3r,3as,6ar)-六氢呋喃[2,3-b]呋喃-3-Yl(2r,3r)-4-(4-氨基-N-异丁基苯基磺基-氨基)-3-羟基-1-的非对映选择性合成苯基丁-2-基氨基甲酸酯(达鲁那韦的非对映异构体)

获取原文
           

摘要

(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl(2S,3S)-4-(4-amino-N-isobutylphenylsulfonamido) -3-hydroxy-1-phenylbutan-2-ylcarbamate 4 was synthesised from 4-amino-N-((2S,3S)-3-amino- 2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfo- namide 3 via N-protected amino alcohol intermeidate 2 while (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-Nisobutylphenylsulfonamido)- 3-(((3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yloxy)carbonyloxy)- 1-phenylbutan-2-yl carbamate 6 was prepared from (3R, 3aS, 6aR)-hexahydrofuro [2, 3-b] furan-3-yl 4-nitrophenyl carbonate 3a. The desired drug 4 was obtained with 99 % diastereoselectivity. The spectroscopic analyses performed by NMR, LCMS, UV–Vis, SOR and FT-IR.
机译:(3R,3aS,6aR)-六氢呋喃[2,3-b]呋喃-3-基(2S,3S)-4-(4-氨基-N-异丁基苯基磺酰胺基)-3-羟基-1-苯基丁烷-2-基氨基甲酸酯4是通过N-保护的氨基醇间甲酸酯2从4-氨基-N-(((2S,3S)-3-氨基-2-羟基-4-苯基丁基)-N-异丁基苯磺酰胺3合成的,而(3R,3aS, 6aR)-六氢呋喃[2,3-b]呋喃-3-基(2S,3R)-4-(4-氨基-异丁基苯基磺酰胺基)-3-((((3R,3aS,6aR)-六氢呋喃[2,3-由[3R,3aS,6aR)-六氢呋喃[2,3-b]呋喃-3-基4-硝基苯基碳酸酯3a制备b]呋喃-3-基氧基)羰基氧基)-1-苯基丁烷-2-基氨基甲酸酯6。获得具有99%非对映选择性的所需药物4。通过NMR,LCMS,UV-Vis,SOR和FT-IR进行光谱分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号